PUR.WA
Price:
$2.175
Market Cap:
$17.40M
Pure Biologics Spólka Akcyjna operates as a biopharmaceutical enterprise, concentrating its efforts on the discovery and development of novel biological pharmaceuticals and targeted, non-systemic treatments. The company's key therapeutic interests span immuno-oncology, various autoimmune conditions, and rare diseases. Its capabilities encompass the entire process for antibodies and aptamers, from their initial creation and purification to detailed analysis and characterization. Additionally, Pure Biologics is skilled in the design, development, and rigorous validation of diagnostic and research assays, while also advancing technology platforms for the precise selection of active therapeutic ...[Read more]
Industry
Biotechnology
IPO Date
2018-12-01
Stock Exchange
WSE
Ticker
PUR.WA
According to Pure Biologics Spólka Akcyjna’s latest financial reports and current stock price. The company's current ROE is 63.00%. This represents a change of 294.16% compared to the average of 15.98% of the last 4 quarters.
The mean historical ROE of Pure Biologics Spólka Akcyjna over the last ten years is -185.78%. The current 63.00% ROE has changed -133.91% with respect to the historical average. Over the past ten years (40 quarters), PUR.WA's ROE was at its highest in in the March 2024 quarter at 161.52%. The ROE was at its lowest in in the December 2023 quarter at -588.38%.
Average
-185.78%
Median
-49.16%
Minimum
-1885.58%
Maximum
419.29%
Discovering the peaks and valleys of Pure Biologics Spólka Akcyjna ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.21%
Maximum Annual ROE = 419.29%
Minimum Annual Increase = -742.88%
Minimum Annual ROE = -1885.58%
| Year | ROE | Change |
|---|---|---|
| 2025 | 69.41% | -53.15% |
| 2024 | 148.18% | -107.86% |
| 2023 | -1885.58% | 1.21% |
| 2022 | -144.13% | 335.41% |
| 2021 | -33.10% | -107.89% |
| 2020 | 419.29% | -742.88% |
| 2019 | -65.22% | 110.13% |
| 2018 | -31.04% | -84.22% |
| 2017 | -196.75% | 41.65% |
The current ROE of Pure Biologics Spólka Akcyjna (PUR.WA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-556.00%
5-year avg
-369.04%
10-year avg
-185.78%
Pure Biologics Spólka Akcyjna’s ROE is greater than Urteste S.A. (-30.55%), greater than Pharmena S.A. (-27.21%), greater than Airway Medix S.A. (-13.65%), greater than BioMaxima S.A. (-0.33%), greater than NanoGroup S.A. (-63.92%), greater than Genomtec S.A. (-95.46%), greater than Poltreg S.A. (-59.09%), greater than Mabion S.A. (-95.68%), less than Adiuvo Investments S.A. (10.32%), greater than Molecure S.A. (-15.59%),
| Company | ROE | Market cap |
|---|---|---|
| -30.55% | $67.30M | |
| -27.21% | $34.64M | |
| -13.65% | $30.85M | |
| -0.33% | $39.42M | |
| -63.92% | $73.01M | |
| -95.46% | $75.93M | |
| -59.09% | $86.74M | |
| -95.68% | $116.37M | |
| 10.32% | $7.01M | |
| -15.59% | $108.99M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pure Biologics Spólka Akcyjna using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pure Biologics Spólka Akcyjna or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Pure Biologics Spólka Akcyjna's ROE?
How is the ROE calculated for Pure Biologics Spólka Akcyjna (PUR.WA)?
What is the highest ROE for Pure Biologics Spólka Akcyjna (PUR.WA)?
What is the 3-year average ROE for Pure Biologics Spólka Akcyjna (PUR.WA)?
What is the 5-year average ROE for Pure Biologics Spólka Akcyjna (PUR.WA)?
How does the current ROE for Pure Biologics Spólka Akcyjna (PUR.WA) compare to its historical average?